Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Senior Principal Investigator, Singapore Immunology Network, Biomedical Sciences Institutes at ASTAR
Dr. Cheng-I Wang joined Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) in 2009 as the head of the Therapeutic Antibody Technology Platform. His research focuses on the discovery, engineering and development of fully human antibodies against infection, immune disorders, and immunotherapeutics against cancers using a combination of structure-based rational design and combinatorial approaches. Dr. Wang received his Ph.D. in Chemistry from Washington University and postdoctoral training in the Department of Pharmaceutical Chemistry at the University of California, San Francisco.